 |
|
Improving Human and Animal Health With Protein Engineering.
|
|
|
|
|
Technology
Design of recombinant proteins with desired
properties
initially became possible in 1982 with the publishing of the first mutagenesis
studies. In these past thirty years, however, successful examples of protein
engineering have been rare. Our technology represents the first successful
design of super active analogs of glycoprotein hormones that shows major
increases in bioactivity and far exceeds results shown for other protein
ligands. |
|
|
Pipeline
Status of Long Acting, Superagonist Human/Animal Product Pipeline (updates are pending)
|
|